The presented figures refer to specimens received during the designated month.
| Nasal swab specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Staphylococcus aureus | No. | 3 | 1 | 3 | 2 | 4 | 3 | 4 | 0 | 3 | 5 | 2 | 2 |
| Penicillin | 100% | 100% | 100% | 100% | 75% | 0% | 75% | - | 67% | 100% | 100% | 100% | |
| Oxacillin [MRSA] |
33% | 0% | 0% | 0% | 25% | 0% | 25% | - | 0% | 20% | 0% | 50% | |
| Clindamycin | 0% | 100% | 0% | 50% | 25% | 0% | 0% | - | 33% | 40% | 100% | 0% | |
| Erythromycin | 0% | 100% | 0% | 50% | 25% | 0% | 0% | - | 33% | 60% | 100% | 0% | |
| Gentamicin | 33% | 0% | 0% | 0% | 0% | 33% | 0% | - | 0% | 40% | 50% | 0% | |
| Throat swab specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Beta-haemolytic streptococcus of Lancefield Group A, C & G | No. | 6 | 3 | 2 | 4 | 4 | 7 | 2 | 4 | 2 | 5 | 7 | 3 |
| Penicillin | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
| Erythromycin | 50% | 33% | 100% | 25% | 25% | 29% | 50% | 50% | 0% | 40% | 29% | 33% | |
| Sputum specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Streptococcus pneumoniae | No. | 5 | 13 | 6 | 7 | 20 | 8 | 9 | 9 | 9 | 13 | 10 | 4 |
| Penicillin | 40% | 46% | 33% | 71% | 35% | 63% | 22% | 22% | 11% | 8% | 0% | 25% | |
| Erythromycin | 80% | 77% | 83% | 100% | 75% | 100% | 78% | 89% | 89% | 85% | 70% | 50% | |
| Levofloxacin | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
| Haemophilus influenzae | No. | 39 | 56 | 92 | 102 | 99 | 59 | 70 | 53 | 34 | 34 | 35 | 25 |
| Ampicillin | 33% | 39% | 43% | 39% | 47% | 36% | 46% | 32% | 56% | 35% | 46% | 36% | |
| Amoxicillin + clavulanic acid | 18% | 18% | 11% | 10% | 8% | 7% | 16% | 15% | 18% | 12% | 14% | 12% | |
| Moraxella catarrhalis | No. | 66 | 50 | 28 | 23 | 11 | 11 | 13 | 5 | 7 | 13 | 34 | 34 |
| BL+ | 91% | 92% | 93% | 100% | 91% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | |
| Urine specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Escherichia coli | No. | 391 | 376 | 494 | 464 | 401 | 473 | 546 | 528 | 544 | 542 | 505 | 513 |
| Ampicillin | 67% | 60% | 67% | 70% | 70% | 68% | 65% | 69% | 66% | 68% | 66% | 67% | |
| Amoxicillin + clavulanic acid | 5% | 6% | 6% | 9% | 6% | 7% | 6% | 7% | 7% | 8% | 7% | 6% | |
| Nalidixic acid | 70% | 66% | 74% | 72% | 67% | 66% | 70% | 69% | 67% | 69% | 69% | 68% | |
| Nitrofurantoin | 2% | 2% | 2% | 1% | 1% | 2% | 2% | 3% | 3% | 2% | 2% | 1% | |
| Co-trimoxazole | 36% | 31% | 40% | 43% | 41% | 43% | 43% | 40% | 40% | 44% | 40% | 38% | |
| Levofloxacin | 30% | 38% | 33% | 31% | 32% | 29% | 29% | 33% | 30% | 28% | 32% | 30% | |
| ESBL+ | 17% | 18% | 18% | 20% | 19% | 18% | 19% | 18% | 22% | 18% | 19% | 17% | |
| Klebsiella pneumoniae^ | No. | 56 | 64 | 71 | 80 | 79 | 48 | 97 | 104 | 108 | 103 | 73 | 84 |
| Amoxicillin + clavulanic acid | 13% | 11% | 7% | 6% | 11% | 6% | 7% | 6% | 11% | 13% | 8% | 8% | |
| Nalidixic acid | 20% | 20% | 24% | 13% | 13% | 23% | 15% | 13% | 16% | 23% | 18% | 19% | |
| Nitrofurantoin | 23% | 31% | 37% | 28% | 30% | 25% | 34% | 44% | 28% | 46% | 29% | 39% | |
| Co-trimoxazole | 23% | 19% | 18% | 15% | 14% | 19% | 20% | 14% | 22% | 24% | 21% | 24% | |
| Levofloxacin | 14% | 13% | 15% | 6% | 9% | 2% | 5% | 7% | 6% | 14% | 14% | 15% | |
| ESBL+ | 11% | 6% | 6% | 10% | 4% | 15% | 18% | 10% | 5% | 12% | 7% | 7% | |
| Proteus mirabilis^^ | No. | 54 | 54 | 62 | 55 | 54 | 49 | 69 | 61 | 73 | 76 | 62 | 70 |
| Ampicillin | 43% | 33% | 29% | 42% | 44% | 27% | 36% | 38% | 33% | 33% | 31% | 40% | |
| Amoxicillin + clavulanic acid | 4% | 4% | 3% | 7% | 9% | 6% | 1% | 8% | 3% | 4% | 0% | 1% | |
| Nalidixic acid | 35% | 35% | 31% | 31% | 41% | 27% | 33% | 36% | 32% | 25% | 26% | 33% | |
| Co-trimoxazole | 35% | 24% | 13% | 25% | 35% | 20% | 30% | 34% | 19% | 28% | 18% | 33% | |
| Levofloxacin | 15% | 13% | 13% | 24% | 24% | 16% | 20% | 21% | 25% | 13% | 18% | 17% | |
| Enteric specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Campylobacter spp. | No. | 1 | 3 | 4 | 0 | 3 | 1 | 1 | 2 | 4 | 0 | 0 | 0 |
| Erythromycin | 0% | 33% | 50% | - | 0% | 0% | 0% | 50% | 0% | - | - | - | |
| Salmonella spp. | No. | 1 | 3 | 5 | 5 | 5 | 12 | 11 | 16 | 17 | 7 | 7 | 5 |
| Ampicillin | 0% | 67% | 100% | 40% | 40% | 42% | 45% | 44% | 53% | 29% | 71% | 20% | |
| Co-trimoxazole | 100% | 33% | 80% | 20% | 20% | 17% | 27% | 13% | 41% | 14% | 43% | 0% | |
| Ciprofloxacin | 100% | 0% | 0% | 0% | 0% | 0% | 0% | 6% | 12% | 0% | 14% | 0% | |
| Shigella spp. | No. | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Ampicillin | - | - | - | - | - | - | 0% | 0% | - | - | - | - | |
| Ciprofloxacin | - | - | - | - | - | - | 0% | 0% | - | - | - | - | |
| Vibrio spp. | No. | 0 | 0 | 0 | 0 | 1 | 3 | 4 | 4 | 3 | 3 | 2 | 0 |
| Tetracycline | - | - | - | - | 0% | 0% | 0% | 0% | 0% | 0% | 0% | - | |
| Soft tissue specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Staphylococcus aureus | No. | 79 | 60 | 83 | 90 | 69 | 72 | 73 | 75 | 68 | 61 | 69 | 61 |
| Oxacillin [MRSA] |
19% | 15% | 23% | 17% | 19% | 17% | 19% | 20% | 24% | 10% | 23% | 28% | |
*Abbreviations:
MRSA = methicillin resistant Staphylococcus aureus
BL+ = beta-lactamse positive
ESBL+ = extended-spectrum beta-lactamase positive
^ Klebsiella pneumoniae is 100% resistant to ampicillin.
^^Proteus mirabilis is 100% resistant to nitrofurantoin.